Coriphar SPRL
0.3 FTECoriphar reported total assets of 425,689 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026), with 0.3 full-time equivalent.
The score of Coriphar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets -16 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Coriphar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 25,225 € | ||||
| Equity | 146,896 € | ||||
| Cash | 62,294 € | ||||
| EBITDA | 33,733 € | ||||
| Total assets | 425,689 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 10 Oct 2025
- Year ended 31 Dec 2023filed on 30 Sep 2024
- Year ended 31 Dec 2022filed on 30 Sep 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Coriphar's financial analysis
- Solvency34.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Coriphar
Coriphar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0437.150.690
- VAT number
- BE0437150690
- Peppol
- Registered · 0208:0437150690 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 04 Apr 1989
- Registered office
- 3300 Tienen
- Size
- Micro · 0.3 FTE
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Coriphar (SPRL) has been based in Tienen since 1989, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,225 € and equity of 146,896 €; its revenue is not published. With 0.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 34.5%, below the median of its sector (44.2%).
Companies similar to Coriphar
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Wostyn Retail sale of pharmaceutical products Tielt · balance sheet 425,166 €
- Apotheke Bocken Retail sale of pharmaceutical products Eupen · balance sheet 426,403 €
- Maxpharma Retail sale of pharmaceutical products Etterbeek · balance sheet 426,986 €
- Pharmacie de Ittre Retail sale of pharmaceutical products Ittre · balance sheet 427,646 €
- D-Pharma Retail sale of pharmaceutical products Schaerbeek · balance sheet 427,889 €
- Maria Brughmans Apotheker Retail sale of pharmaceutical products Baarle-Hertog · balance sheet 429,618 €
- Benatpharma Retail sale of pharmaceutical products Jette · balance sheet 420,772 €
- Essential Pharma Retail sale of pharmaceutical products Seraing · balance sheet 430,671 €
Frequently asked questions about Coriphar
What is the revenue of Coriphar?
Coriphar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Coriphar?
In Belgium, the VAT number is the company number prefixed with BE: BE0437150690 for Coriphar, if the company is VAT-registered. Its company number (CBE) is 0437.150.690.
Where is the registered office of Coriphar?
According to the CBE register, the registered office of Coriphar is in 3300 Tienen.
What is the equity of Coriphar?
At the close of the 2025 financial year, the equity of Coriphar amounts to 146,896 €, a solvency of 34.5% of total assets.
How many people work at Coriphar?
0.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Coriphar?
The register lists 2 active mandates at Coriphar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Coriphar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →